A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Public ClinicalTrials.gov record NCT07521007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-controlled Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of YN001 in Adults With Coronary Atherosclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.
Study identification
- NCT ID
- NCT07521007
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 456 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2026
- Primary completion
- Jul 30, 2027
- Completion
- Mar 30, 2029
- Last update posted
- Jul 13, 2026
2026 – 2029
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Heart Center Research, LLC | Huntsville | Alabama | 35801 | — |
| Clinical Trials Research | Lincoln | California | 95648 | — |
| Stanford University School of Medicine | Stanford | California | 94305 | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| Excel Medical Clinical Trials dba Flourish Research - Boca Raton | Boca Raton | Florida | 33434 | — |
| HCA Florida Heart Institute | Petersburg | Florida | 33709 | — |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62781 | — |
| Midwest Heart & Vascular Specialists | Overland Park | Kansas | 66209 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital | Cincinnati | Ohio | 45219 | — |
| Capital Area Research | Camp Hill | Pennsylvania | 17011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
Recently updated Atherosclerosis trials
Other public records listing Atherosclerosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07783802: A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event Not yet recruiting
- NCT07613294: A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk Recruiting
- NCT05867381: Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History Recruiting
- NCT04496947: Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study Recruiting
- NCT01399385: New Heart Imaging Techniques to Evaluate Possible Heart Disease Recruiting
- NCT07448038: A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07521007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 13, 2026 · Synced Aug 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07521007 live on ClinicalTrials.gov.